secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0000950170-22-024462
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences Q3 revenue down 21% YoY to $1.9M; GoodWheat hits 1,000 stores
--------------------------------------------------------------------------------

- Q3 2022 revenue $1.9M vs $2.4M in Q3 2021, driven by lower body care/GLA, partly offset by GoodWheat pasta.
- Gross margin improved to 28% (cost of revenues $1.3M); operating expenses cut 42% to $6.5M.
- Net loss attributable to common stockholders $2.9M ($0.12 per share) vs $2.2M ($0.10) in Q3 2021.
- GoodWheat pasta distribution doubled from Q2 to ~1,000 stores, reaching year-end goal early.
- Company streamlined operations by divesting Saavy Naturals brand and manufacturing facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022024462/0000950170-22-024462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022024462/rkda-20221110.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-024462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer